High endothelial venules (HEVs) in human melanoma lesions: Major gateways for tumor-infiltrating lymphocytes - Wikidata - awgldk - TriplyDB

High endothelial venules (HEVs) in human melanoma lesions: Major gateways for tumor-infiltrating lymphocytes

High endothelial venules (HEVs) in human melanoma lesions: Major gateways for tumor-infiltrating lymphocytes

http://www.wikidata.org/entity/Q36373347

about

Tertiary Lymphoid Organs in Cancer Tissues New Strategies for the Treatment of Solid Tumors with CAR-T Cells Ectopic lymphoid follicles: inducible centres for generating antigen-specific immune responses within tissues Control of CD8 T-Cell Infiltration into Tumors by Vasculature and Microenvironment Understanding high endothelial venules: Lessons for cancer immunology Innate and adaptive immune cells in the tumor microenvironment Characteristics of tertiary lymphoid structures in primary cancers Understanding Immune Cells in Tertiary Lymphoid Organ Development: It Is All Starting to Come Together Tertiary Lymphoid Structures in Cancers: Prognostic Value, Regulation, and Manipulation for Therapeutic Intervention Melanoma-infiltrating dendritic cells: Limitations and opportunities of mouse models Effector lymphocyte-induced lymph node-like vasculature enables naive T-cell entry into tumours and enhanced anti-tumour immunity Predictive Value of Tertiary Lymphoid Structures Assessed by High Endothelial Venule Counts in the Neoadjuvant Setting of Triple-Negative Breast Cancer.Tertiary Lymphoid Structure-Associated B Cells are Key Players in Anti-Tumor Immunity.Combination of IFNα and poly-I:C reprograms bladder cancer microenvironment for enhanced CTL attraction.Role of dendritic cells in the regulation of antitumor immunity Tertiary lymphoid structures are confined to patients presenting with unifocal Langerhans Cell Histiocytosis Contribution of humoral immune responses to the antitumor effects mediated by anthracyclines.Role of the Lymphotoxin/LIGHT System in the Development and Maintenance of Reticular Networks and Vasculature in Lymphoid Tissues Correlation between High Endothelial Vessels and Histopathological Features of Different Pigmented Lesions.Manipulation of tumour-infiltrating B cells and tertiary lymphoid structures: a novel anti-cancer treatment avenue?Shaping of an effective immune microenvironment to and by cancer cells.Immunotherapy in Cancer: A Combat between Tumors and the Immune System; You Win Some, You Lose Some.Targeting TNF alpha as a novel strategy to enhance CD8(+) T cell-dependent immune response in melanoma?Homing to solid cancers: a vascular checkpoint in adoptive cell therapy using CAR T-cells.Tertiary lymphoid structures, drivers of the anti-tumor responses in human cancers.T-lymphocyte homing: an underappreciated yet critical hurdle for successful cancer immunotherapy.High Endothelial Venules and Other Blood Vessels: Critical Regulators of Lymphoid Organ Development and Function Lymphotoxin signalling in tertiary lymphoid structures and immunotherapy.Fine-Tuning Tumor Endothelial Cells to Selectively Kill Cancer.High endothelial venules are rare in colorectal cancers but accumulate in extra-tumoral areas with disease progression.Tbet and IL-36γ cooperate in therapeutic DC-mediated promotion of ectopic lymphoid organogenesis in the tumor microenvironment.Combined antiangiogenic and anti-PD-L1 therapy stimulates tumor immunity through HEV formation.Regulation of tumor-associated high-endothelial venules by dendritic cells: A new opportunity to promote lymphocyte infiltration into breast cancer?Alterations of high endothelial venules in primary and metastatic tumors are correlated with lymph node metastasis of oral and pharyngeal carcinoma.The density and type of MECA-79-positive high endothelial venules correlate with lymphocytic infiltration and tumour regression in primary cutaneous melanoma.Tertiary Lymphoid Structures in Cancer: Drivers of Antitumor Immunity, Immunosuppression, or Bystander Sentinels in Disease?Ectopic lymphoid structures in primary cutaneous melanoma.Presence of tumour high-endothelial venules is an independent positive prognostic factor and stratifies patients with advanced-stage oral squamous cell carcinoma.Complete intracranial response to talimogene laherparepvec (T-Vec), pembrolizumab and whole brain radiotherapy in a patient with melanoma brain metastases refractory to dual checkpoint-inhibition.Targeting VEGF/VEGFR to Modulate Antitumor Immunity.

P2860

Q26742168-FAF8CD2D-485F-4E52-99F6-499C4F078C8C Q26748500-AAFDA1E9-0274-4944-9EC9-B86E980D2C80 Q26778348-2BECDA78-7F2F-464A-9C6D-76678E7E7F90 Q26799117-6C84E8B4-8159-4B8F-962C-1B20270CA7C6 Q27005794-F9EBA1A0-3480-4214-9E1B-991C5C0255E6 Q27008342-1A6EB407-00FC-499F-AEB9-63346A60AB50 Q27012852-D36A8753-996B-4486-9678-DCDF50EB3536 Q28067648-1644E5D3-DD37-449C-ACB3-C38C93D74B1D Q28073895-88EBF25C-70FE-4425-AA49-3EC469C6AFE2 Q28392156-77632EB6-BE57-4789-9B77-2F87B913761D Q30299955-995F2AF6-C2E7-4423-9332-9DC19C83EEA7 Q33584033-62BBA134-906D-4D1D-9B72-EA554AEA9CF4 Q35110486-B135D0CC-BCB8-45D7-AA67-9F41DA3B5CED Q35212274-BBFFD080-2110-4BF9-A133-97AE2807CED0 Q36845842-6197C77F-1098-47C7-9CA1-70767625D7ED Q37224600-7032C113-8D97-404E-A657-91013D6296D5 Q37379398-960C780C-3705-45F8-BE9E-F53A2313ABAA Q37576573-4EEFAFA7-B3FC-41F6-B5F6-B2203B652B83 Q37734253-55785C78-1566-46FB-8306-017A757423D0 Q38201655-EE84D694-5774-44DD-90F4-0AAE3421CCA4 Q38238941-C33859E2-9D6D-41B7-9D15-3DE2A12B6E0A Q38413904-8C2F03A4-3B33-4E6B-B947-F1026940F8B1 Q38563773-540E2A81-208C-4154-AF44-8FD948A2E5C9 Q38805749-75BA3DE6-A3F1-4FE2-800B-4E12B74748D5 Q38810926-2F040524-2AD5-46EB-A20F-0198CED1ED18 Q38873974-DC2C39CB-DBAC-41D7-B89A-9A4BC399FAC2 Q39143550-C8E022A6-8712-4C4D-9E47-D7B8BC175FA8 Q39245218-FC5D8933-0C00-4948-A9F5-05A1ED838677 Q39406918-DC219679-C41D-4E7A-994B-A6D547EDAC05 Q39832756-F3D20FAA-3AFC-430B-BBFB-17E565DDE0EC Q40146273-A07053CB-24D9-417F-BC19-DBA59027A79D Q41369903-87941E3B-4B7D-4A71-9B75-9E5AE4E6B82B Q41882516-E8831B73-53B9-44ED-850A-391D4D97CC27 Q42737895-192CECB9-1C7A-49DB-B2BF-49CB3EFCDFFD Q45403989-D439D62A-5963-4D12-9BCC-D018F5943C6B Q47194123-3C0CDC19-5DA1-4DAA-A44C-631A97113131 Q50850999-ECDDAC5D-1E30-4185-80F3-80D04B08EE52 Q50854491-04793C37-97E0-40EE-AFD0-2565F5CAAD09 Q52604125-D9733D2B-2752-4538-9C72-27929860C820 Q55008337-4FD30FA5-A329-40D8-8B39-197FED53E03A

P2860

High endothelial venules (HEVs) in human melanoma lesions: Major gateways for tumor-infiltrating lymphocytes

http://www.wikidata.org/entity/Q36373347

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

High endothelial venules (HEVs ...... tumor-infiltrating lymphocytes

@ast

High endothelial venules (HEVs ...... tumor-infiltrating lymphocytes

@en

type

label

High endothelial venules (HEVs ...... tumor-infiltrating lymphocytes

@ast

High endothelial venules (HEVs ...... tumor-infiltrating lymphocytes

@en

prefLabel

High endothelial venules (HEVs ...... tumor-infiltrating lymphocytes

@ast

High endothelial venules (HEVs ...... tumor-infiltrating lymphocytes

@en

P1433

Q36373347-2D598611-029F-49D2-9AA1-797E427C8D13

P1476

Q36373347-B8735B5C-D739-422B-9C4C-5A5744F5CE93

P2093

Q36373347-1D1A2C9E-8DAA-4348-8228-CD72C8B32049

Q36373347-2743B6E2-33E6-4ECE-B09C-508FFF382351

Q36373347-B4A030A0-F8B9-4286-96AA-3CE802E0E489

Q36373347-C37C70C1-BD54-4633-9033-956AC0DCE180

Q36373347-F1F63BDB-EA2E-48D5-AB13-63E2B3A1264F

P2860

Q36373347-02FB907E-4069-4477-8E71-94B33175E1ED

Q36373347-05BD9100-3C33-4A01-9501-B43693A13FD6

Q36373347-0682B4FB-574C-40F9-94D4-A5DE6D19EA0D

Q36373347-187E499C-CD9F-451B-9DBA-135A237436DD

Q36373347-2DD97D00-591D-4ED9-A6D2-BBEC9357DD03

Q36373347-3E6450CA-8D2B-407A-BE9C-442C49166236

Q36373347-439666D9-0D60-4EC4-BEE5-46945A866530

Q36373347-453563AD-399E-4243-AC3A-60C42E9D0EDA

Q36373347-4A3E22D2-85C8-4DE5-A92C-49C9955D11F8

Q36373347-52515283-11A0-4E5A-AA39-9FAA7E065080

P304

Q36373347-80846220-62FF-4327-BF19-E5FADA77272B

P31

Q36373347-1B6E1484-EF78-48C0-9C86-05D1A5663EB5

P356

Q36373347-CB2C0ACD-58C5-4D68-91AD-505945DB5853

P433

Q36373347-A4F63414-F382-4051-8CB7-B466AB40F97C

P478

Q36373347-C4EF2CBF-D81D-42CC-A010-87AF06A3DD7D

P50

Q36373347-09D118A2-EBBF-4A56-BAD7-0A8B908B2B77

Q36373347-600BDA85-F623-480F-9374-A6E6ACB95771

Q36373347-7E2C5674-F1FA-495D-983F-73836C1B6023

P577

Q36373347-10F68E03-0B47-467C-9745-543D8CC0F4F7

P5875

Q36373347-9919D398-7DD8-46A9-BA3E-84CB8055641E

P698

Q36373347-2FB5DDAD-45C4-431D-9609-9C1ADDA0AFFF

P921

Q36373347-213A4BBD-86D4-4DAC-B9FF-74AFD82F0FC1

Q36373347-2E8B61D3-BA4A-4C5A-99D7-6B7FDEFD44F7

P932

Q36373347-E7A1EAFE-4AE2-4EE9-B05E-9C0C53DF3ECC

P356

P1433

P1476

High endothelial venules (HEVs ...... tumor-infiltrating lymphocytes

@en

P2093

Ignacio Garrido

http://www.w3.org/2001/XMLSchema#string

Jean-Philippe Girard

http://www.w3.org/2001/XMLSchema#string

Laurence Lamant

http://www.w3.org/2001/XMLSchema#string

Nicolas Meyer

http://www.w3.org/2001/XMLSchema#string

Sophie Le Guellec

http://www.w3.org/2001/XMLSchema#string

P2860

Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma

Ipilimumab plus dacarbazine for previously untreated metastatic melanoma

Type, density, and location of immune cells within human colorectal tumors predict clinical outcome

High endothelial venules (HEVs): specialized endothelium for lymphocyte migration

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

Final version of 2009 AJCC melanoma staging and classification

Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer

Natural innate and adaptive immunity to cancer

Dendritic cells control lymphocyte entry to lymph nodes through high endothelial venules

Tumor masses support naive T cell infiltration, activation, and differentiation into effectors

P304

829-839

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4161/ONCI.20492

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

1

http://www.w3.org/2001/XMLSchema#string

P50

Philippe Rochaix

Thomas Filleron

Ludovic Martinet

P577

2012-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

233539941

http://www.w3.org/2001/XMLSchema#string

P698

23162750

http://www.w3.org/2001/XMLSchema#string

P921

P932

3489738

http://www.w3.org/2001/XMLSchema#string